GlassScriptPhysician profile
Frank James Rivera
NPI 1760437305
$5,564.70
in general payments reported to CMS, 2019-2025
20 companies · $86.45 in 2025
The $86.45 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,757 · 2020: $1,016 · 2021: $314 · 2022: $235 · 2023: $104 · 2024: $51.85 · 2025: $86.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,648.60 | 2019 | |
| Merit Medical Systems INC | $995.10 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $182.13 | 2020-2023 | Farxiga |
| Veloxis Pharmaceuticals, INC. | $160.08 | 2019-2023 | Envarsus |
| Cook Medical LLC | $128.56 | 2021-2025 | Zilver Ptx |
| Mallinckrodt Hospital Products INC. | $72.37 | 2022-2023 | Acthar |
| Boston Scientific Corporation | $53.59 | 2019 | |
| Aurinia Pharma U.S., INC. | $45.40 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.71 | 2022-2023 | Livtencity |
| Argon Medical Devices, INC. | $36.49 | 2021 | |
| Cormedix INC. | $33.37 | 2024 | Defencath |
| Amarin Pharma, INC. | $32.81 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.66 | 2025 | Jardiance |
| Abbott Laboratories | $19.94 | 2019 | |
| Lilly USA, LLC | $18.48 | 2024 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.68 | 2021 | |
| Angiodynamics, INC. | $15.44 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.18 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.90 | 2022 | |
| Covidien LP | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.